Health Economics and Policy

Raising awareness and understanding of a largely misunderstood condition: the Charles Bonnet Syndrome

When even the world’s wealthiest economies struggle to fund gene therapies, we have a problem that demands disruptive solutions

The RCOphth National Ophthalmology Database (NOD) Audit can provide richer outcomes analysis than any single individual or institution – and cost less

Could combining inflow and outflow procedures be a new strategy for combating glaucoma?

It is time for ophthalmology to embrace refractive surgery – for the sake of humankind

Sitting Down With… Audrey Talley Rostov, Northwest Eye Surgeons and and SightLife

Thanks to European approval of a new indication for Lucentis, preterm infants with ROP finally have a pharmacotherapeutic option

Drugs used to treat retinal disorders appear to pass into breast milk, posing a potential risk to the normal development of nursing infants

Three diabetic eye disease gurus discuss prevention, detection, diagnosis, and treatment – and explain why it’s important to consider the future

AI image interpretation will not solve the diabetic retinopathy epidemic